Latest News and Press Releases

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024

Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer

Sandeep Kulkarni, CEO of Tourmaline Bio, is expected to participate in the Jefferies Global Healthcare Conference in New York on June 9, 2024

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial